Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
Vaccine|June 24, 2020
Assessing the completeness of infant and childhood immunizations within a provincial registry populated by parental reporting: A study using linked databases in Ontario, CanadaSarah E Wilson, Andrew S Wilton, Jacqueline Young, et al.
Vaccine|April 4, 2012
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) studyJoanne M Langley, David W Scheifele, Caroline Quach, et al.
The Lancet. Infectious Diseases|April 24, 2017
Maternal immunisation: collaborating with mother natureArnaud Marchant, Manish Sadarangani, Mathieu Garand, et al.
Emerging Infectious Diseases|February 25, 2020
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada1Joanne M Langley, Soren Gantt, Caroline Quach, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
Human Vaccines & Immunotherapeutics|November 12, 2016
Assessing the risk of intussusception and rotavirus vaccine safety in CanadaSteven Hawken, Robin Ducharme, Laura C Rosella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2020
Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network StudyKarina A Top, Wendy Vaudry, Shaun K Morris, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
The Journal of Pediatrics|May 15, 2025
Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive StudyKarina A Top, Julie A Bettinger, Joanne E Embree, et al.
Plos One|June 11, 2025
Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)Pedro Cahn, Luis Barreto, Maria Ines Figueroa, et al.
Pageof 34